Showing 1 - 6 results of 6 for search 'Knut Jørgen Labori', query time: 0.03s Refine Results
  1. 1
    Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives

    Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives by Knut Jørgen Labori, Knut Jørgen Labori

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Pancreatic duct occlusion with polychloroprene-based glue for the management of postoperative pancreatic fistula after pancreatoduodenectomy—an outdated approach?

    Pancreatic duct occlusion with polychloroprene-based glue for the management of postoperative pancreatic fistula after pancreatoduodenectomy—an outdated approach? by Sheraz Yaqub, Sheraz Yaqub, Bård Røsok, Ivar Prydz Gladhaug, Ivar Prydz Gladhaug, Knut Jørgen Labori, Knut Jørgen Labori

    Published 2024-04-01
    Get full text
    Article
  3. 3
    Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma

    Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma by Manoj Amrutkar, Caroline S. Verbeke, Anette Vefferstad Finstadsveen, Linda Dorg, Knut Jørgen Labori, Ivar P. Gladhaug

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Preoperative CTC-Detection by CellSearch<sup>®</sup> Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer

    Preoperative CTC-Detection by CellSearch<sup>®</sup> Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer by Harald Hugenschmidt, Knut Jørgen Labori, Elin Borgen, Cathrine Brunborg, Cecilie Bendigtsen Schirmer, Lars Thomas Seeberg, Bjørn Naume, Gro Wiedswang

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial

    Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre rando... by Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, Jon Erik Grønbech, Jon Arne Søreide, Kim Mortensen, Rune Smaaland, Halfdan Sorbye, Caroline Verbeke, Svein Dueland

    Published 2017-08-01
    Get full text
    Article
  6. 6
    Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information

    Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information by Harald Hugenschmidt, Knut Jørgen Labori, Cathrine Brunborg, Caroline Sophie Verbeke, Lars Thomas Seeberg, Cecilie Bendigtsen Schirmer, Anne Renolen, Elin Borgen, Bjørn Naume, Gro Wiedswang

    Published 2020-11-01
    Get full text
    Article

Search Tools: